Capstan Therapeutics
Adrian Bot, M.D., Ph.D., is Capstan’s founding Chief Scientific Officer, leading the research and development activities. Adrian has 25 years of experience in biopharmaceutical industry, was formerly the first Chief Scientific Officer of Kite Pharma and more recently, Global Head and Vice President of Translational Medicine and Santa Monica Research Site Head at Kite, a Gilead Company.
This person is not in any offices
Capstan Therapeutics
2 followers
Capstan Therapeutics is advancing precision in vivo cell engineering to develop therapeutics for a broad range of disease categories with unmet or underserved clinical need.